of that Regulation lays down that any person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an application in accordance with Article 7, in addition, Article 10(2) of that Regulation specifies that for existing products within the meaning of Article 10(1), an application shall be submitted in accordance with Article 7, within a maximum of 7 years after the entry into force of this Regulation.
The European Commission received a request from the Feed Flavourings Authorisation Consortium European Economic Interest Grouping (FFAC EEIG) 2 for authorisation of 43 substances (geraniol, hex-2-en- 1-ol, 3,7,11-trimethyldodeca-2,6 ,10-trien-1-ol, nona-2,6-dien-1-ol, pent-2-en-1-ol, nerol, non-2(cis)-en-1-ol, tr-2, cis-6-nonadien-1-ol, citral (mixture of geranial and neral), 2-dodecenal, nona-2(trans),6 (cis)-dienal, nona-2,4-dienal, trans-2-nonenal, hex-2(trans)-enal, 2,4-decadienal, 2,4-heptadienal (or hepta-2,4-dienal) , deca-2(trans),4(trans)-dienal, dodec-2(trans)-enal, hept-2(trans)-enal, non-2-enal, nona-2(trans),6(trans)-dienal, undec-2(trans)-enal, trans-2-octenal, trans-2-decenal, tr-2, tr-4-nonadienal, tr-2, tr-4-undecadienal, 2-methyl-2-pentenoic acid, 2-methylcrotonic acid, geranyl acetate, geranyl butyrate, geranyl formate, allyl heptanoate, geranyl propionate, neryl propionate, neryl formate, neryl acetate, allyl hexanoate, ethyldeca-2(trans),4(cis)-dienoate, hex-2(trans)-enyl acetate, hex-2-enyl butyrate, neryl isobutyrate, geranyl isobutyrate and prenyl acetate) belonging to chemical group (CG) 3, when used as a feed additive for all animal species (category: sensory additives; functional group: flavourings). CG 3 for flavouring substances is defined in Commission Regulation (EC) No 1565/2000 3 as 'a,b-unsaturated (alkene or alkyne) straight-chain and branched-chain aliphatic primary alcohols/ aldehydes/acids, acetals and esters with esters containing a,b-unsaturated alcohol and acetal containing a,b-unsaturated alcohols or aldehydes. No aromatic or heteroaromatic moiety as a component of an ester or acetal.' During the course of the assessment, this application was split and the present opinion covers 26 out of the 43 substances under application (see Section 1.2).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the application to the European Food Safety Authority (EFSA) as an application under Article 4(1) (authorisation of a feed additive or new use of a feed additive) and under Article 10(2) (re-evaluation of an authorised feed additive). During the course of the assessment, the applicant withdrew the application for the use of chemically defined flavourings in water for drinking. 4 EFSA received directly from the applicant the technical dossier in support of this application. The particulars and documents in support of the application were considered valid by EFSA as of 1 December 2010.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and documents submitted by the applicant, shall undertake an assessment in order to determine whether the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the safety for the target animals, consumer, user and the environment and on the efficacy of hex-2-en-1-ol [EU Flavour Information System (FLAVIS) 
1.2.

Additional information
The initial application concerned 43 compounds assigned to this CG, intended to be used as feed flavourings for all animal species. The EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) has already delivered an opinion on 17 out of the 43 compounds (EFSA FEEDAP Panel, 2016) .
The remaining 26 compounds were excluded from the previous assessment because the EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) was not in the position to conclude on the genotoxicity of this group of compounds and expressed the need for additional data to complete the assessment (EFSA CEF Panel, 2014a,b) . Subsequently, the EFSA CEF Panel delivered two opinions on the 26 compounds, concluding that there are no genotoxicity concerns (EFSA CEF Panel, 2018; EFSA FAF Panel, 2018 The 26 compounds are currently listed in the European Union (EU) database of flavouring substances (also named Union list) 5 and in the EU Register of Feed Additives, 6 and thus authorised for use in food and feed in the EU. They have not been previously assessed by EFSA as feed additives.
2.
Data and methodologies
Data
The present assessment is based on data submitted by the applicant in the form of a technical dossier 7 in support of the authorisation request for the use of 'a,b-unsaturated straight-chain and branched-chain aliphatic primary alcohols, aldehydes, acids and esters' as feed additives.
The FEEDAP Panel used the data provided by the applicant together with data from other sources, such as previous risk assessments by EFSA or other expert bodies, peer-reviewed scientific papers, other scientific reports and experts' knowledge, to deliver the present output.
EFSA has verified the EU Reference Laboratory (EURL) report as it relates to the methods used for the control of the 'a,b-unsaturated (alkene or alkyne) straight-chain and branched-chain aliphatic primary alcohols, aldehydes, acids, acetals and esters with esters containing a,b-unsaturated alcohol and acetal containing a,b-unsaturated alcohols or aldehydes. No aromatic or heteroaromatic moiety as a component of an ester or acetal in animal feed.' The Executive Summary of the EURL report can be found in Annex A. 
Assessment
The additives under assessment are 26 compounds belonging to CG 3 -'a,b-unsaturated (alkene or alkyne) straight-chain and branched-chain aliphatic primary alcohols/aldehydes/acids, acetals and esters with esters containing a,b-unsaturated alcohol and acetal containing a,b-unsaturated alcohols or aldehydes', intended for use as sensory additives (functional group: flavouring compounds) in feed for all animal species.
Characterisation 3.1.1. Characterisation of flavouring substances
The molecular structures of the 26 additives under assessment are shown in Figure 1 and their physicochemical characteristics in Table 1 . The 26 compounds are all synthetically produced. Typical routes of synthesis are described for each compound.
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Data were provided on the batch to batch variation in five batches of each additive except five compounds. Owing to the low use volume (< 2 kg/year), data on two batches were provided for nona-2,6-dien- 11 For non-2(cis)-en- 1-ol [02.112] , no data on the purity were provided. Therefore, this compound was excluded from further assessment. For the remaining 25 compounds, the content of the active substance exceeded the JECFA specifications ( Table 2) . Potential contaminants are considered as part of the product specification and are monitored as part of the Hazard Analysis and Critical Control Point procedure applied by all consortium members. The parameters considered include residual solvents, heavy metals and other undesirable substances. However, no evidence of compliance was provided for these parameters.
Shelf-life
The shelf-life of the compounds under assessment is stated to range from 8 to 36 months, when stored in closed containers under recommended conditions. This assessment is made on the basis of compliance with the original specification over this storage period.
Conditions of use
The applicant proposes the use of all of the 25 compounds under assessment in feed for all animal species without withdrawal time. For all the additives, the applicant proposes a normal use level of 1 mg/kg feed and a high use level of 5 mg/kg complete feed.
Safety
The assessment of safety is based on the high use level proposed by the applicant (5 mg/kg complete feed).
The compounds under assessment have been recently evaluated by EFSA as food flavourings (EFSA CEF Panel, 2018; EFSA FAF Panel, 2018).
Absorption, distribution, metabolism and excretion
The compounds of CG 3 under assessment in the present opinion are primary unsaturated alcohols, aldehydes (enals and dienals) and esters. In general, compounds belonging to CG 3 are rapidly absorbed, distributed, metabolised and excreted (WHO, 1997 (WHO, , 1999 (WHO, , 2004a (WHO, ,b, 2005 (WHO, , 2006 EFSA CEF Panel, 2010 , 2013 .
In 2016, the FEEDAP Panel delivered an opinion on 17 compounds belonging to CG 3 and summarised the metabolic pathways involved in their biotransformation (EFSA FEEDAP Panel, 2016) . The 25 compounds under assessment are metabolised via the same metabolic pathways: (i) hydrolysis of esters; (ii) oxidation of linear alcohols and aldehydes to acids by high capacity NAD+/NADP-dependent enzymes; (iii) reduction of aldehydes to alcohols by NAD(P)H-dependent reductases; (iv) conjugation of alcohols with glucuronic acid; (v) b-oxidation of carboxylic acids. The a,b-unsaturated enals and dienals are expected to be oxidised to the corresponding acid which is completely metabolised in the fatty acid b-oxidation pathway (b-oxidative cleavage and complete metabolism via the tricarboxylic acid cycle). Due to their electrophilic characteristics, they can also be detoxified by conjugation with glutathione, directly or enzyme mediated, and excreted as mercapturic acid derivatives (WHO, 2004b (WHO, , 2006 . ADME studies in laboratory animals were made available for trans-2-nonenal [05.072] and trans-2-hexenal [05.073]. They are shortly described below.
Male Wistar rats (n = 10) were given by gavage trans-2-nonenal or trans-2-hexenal as a single dose of 100 mg/kg body weight (bw). Analyses of urine by proton nuclear magnetic resonance spectroscopy ( 1 H-NMR) confirmed that trans-2-nonenal is absorbed from the gastrointestinal tract into the systemic circulation and excreted in the urine mainly as C3 mercapturate conjugates within 24 h. Trace amounts of trans-2-nonenal were detected in the faeces. The analysis of the stomach contents of rats 16 h after administration of trans-2-nonenal showed that approximately 15% of the administered dose had been oxidised to trans-2-nonenoic acid (Grootveld et al., 1998 , as referenced in WHO, 2006 . The major urinary metabolite isolated from the urine of male Wistar rats given trans-2-pentenal or trans-2-nonenal was the mercapturic acid conjugate of the corresponding alcohol, 3-S-(Nacetylcysteinyl)pentan-1-ol or 3-S-(N-acetylcysteinyl)nonan-1-ol, respectively. Low concentrations of glucuronic acid conjugates were also detected in the urine. The authors suggested that these conjugates arose from a sequential pathway involving thiol conjugation, oxidation or reduction of the aldehyde functional group, followed by glucuronic acid conjugation of the resulting carboxylic acid or alcohol, respectively (Grootveld et al., 1998 , as referenced in WHO, 2006 .
Studies of metabolism of compounds belonging to CG 3 in animals other than rodents are lacking in the scientific literature.
12 However, the enzymes involved in the biotransformation pathways of these compounds are present in all target species (reviewed in EFSA FEEDAP Panel, 2016). Therefore, foodproducing animals, including fish and birds, as well as non-food-producing animals can also be assumed to have the ability to metabolise and excrete the 25 flavourings under assessment.
Toxicological studies
Toxicological data (subchronic studies or other repeated-dose studies with multiple doses tested) were submitted only for hex-2(trans)-enal [05.073] and deca-2(trans),4(trans)-dienal [05.140] .
In a subchronic study in rats (males/females, 15 animals/sex and group), hex-2(trans)-enal [05.073] was administered with the diet at doses of 0, 260, 640, 1,600 and 4,000 mg/kg for 13 weeks. The study examined body weight, feed intake, haematology (at weeks 6 and 13), gross pathology and histopathological changes. At the highest dose tested, a slight but not significant reduction in growth was observed associated with reduced feed intake, most probably due to reduced palatability. A relatively low specific gravity and a large urinary volume observed in males at 4,000 mg/kg suggested a minimal degree of renal dysfunction, not supported by urine analysis, kidney weight and histology. A no observed adverse effect level (NOAEL) of 1,600 mg/kg corresponding to 80 mg/kg bw per day was identified by the authors of the study for hex-2(trans)-enal (Gaunt et al., 1971) . The FEEDAP Panel agrees with the NOAEL of 80 mg/kg bw per day identified for hex-2(trans)-enal from this study.
Because of similarity in structure and metabolism, the FEEDAP Panel considers that the NOAEL identified for hex- The subchronic toxicity of deca-2(trans),4(trans)-dienal [05.140] was tested in rats (males/females, 6 animals/sex and group) for 13 weeks. The test item was administered with the diet at doses 0, 3.39, 10.70 and 33.90 mg/kg bw per day. The study examined mortality, body weight, haematology, clinical chemistry and urinalysis (at weeks 6 and 12), gross pathology and histopathology. No adverse effects associated with the treatment were observed. The NOAEL identified by the authors of the study was 34 mg/kg bw per day, the highest dose tested (Damske et al., 1980) . The FEEDAP Panel agrees with the NOAEL of 34 mg/kg bw per day identified for deca-2(trans),4(trans)-dienal form this study.
Because of similarity in structure and metabolism, the FEEDAP Panel considers that the NOAEL identified for deca-2(trans), 4 
Safety for the target species
The maximum feed concentration which can be considered safe for the target animals can be derived from the lowest NOAEL identified if suitable data are available (EFSA FEEDAP Panel, 2012a) .
Toxicological data derived from a subchronic study were only available for hex- -2, tr-4-nonadienal [05.194] and tr-2, tr-4-undecadienal [05.196] (see Section 3.2.2) . Applying an uncertainty factor (UF) of 100 to the NOAELs derived from subchronic studies, the maximum safe intake for the target species was derived following the EFSA Guidance on sensory additives (EFSA FEEDAP Panel, 2012a) , and thus, the maximum safe feed concentration was calculated (see Table 3 ).
Since individual reliable NOAELs could not be found for the six remaining compounds, the threshold of toxicological concern (TTC) approach was followed to derive the maximum safe feed concentration (EFSA FEEDAP Panel, 2012a 
Safety for the consumer
The safety for the consumer of the 25 compounds used as food flavours has been already assessed by JECFA (WHO, 1999 (WHO, , 2004a (WHO, ,b, 2005 and EFSA (EFSA CEF Panel, 2018; EFSA FAF Panel, 2018) . All compounds are currently authorised in the EU as food flavourings without limitations. Although deposition and residue studies of the compounds in farm animals are not available, the FEEDAP Panel considers that the use of these flavourings in animal feed would not appreciably increase the human exposure to these compounds. This is based on the low use levels to be applied in feed and the expected extensive metabolism and excretion in target animals (see Section 3.2.1). Consequently, no safety concern would arise for the consumer from the use of these 25 compounds up to the highest levels considered safe for target animals (1 or 5 mg/kg complete feed).
Safety for the user
The applicant as required produced a safety data sheet 13 for each compound where hazards for users have been identified. No studies to assess the safety for the user were submitted. Therefore, the FEEDAP Panel cannot conclude on the safety for the users when handling the additive.
Safety for the environment
The compounds under assessment are naturally occurring in the environment 14 or expected to be fully metabolised to carbon dioxide and water either in the animal (see Section 3.2.1) or subsequently in the environment. Consequently, their use in animal nutrition at the concentrations in feed considered safe for the target species is also considered safe for the environment.
Efficacy
Since the 25 compounds are used in food as flavourings, and their function in feed is essentially the same as that in food, no further demonstration of efficacy is necessary (EFSA FEEDAP Panel, 2012a).
Conclusions
The FEEDAP Panel was unable to perform an assessment of non-2(cis)-en- No safety concern would arise for the consumer from the use of these compounds up to the highest safe levels in feed.
In the absence of studies to assess the safety for the user, the FEEDAP Panel cannot conclude on the safety for the users when handling the additives.
No environmental risk is foreseen for these compounds at the concentrations considered safe for the target species.
Since all of the compounds under assessment are used in food as flavourings and their function in feed is essentially the same as that in food, no further demonstration of efficacy is necessary. WHO 
